African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 15, Issue 4, 2014, Pages 214-218

  Gaglia, Michael A ^a   Shavelle, David M ^a   Tun, Han ^a   Bhatt, Jiken ^a   Mehra, Anilkumar ^a   Matthews, Ray V ^a   Clavijo, Leonardo ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Drug eluting stents; Healthcare disparities; Insurance; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; MEDICARE; OUTCOME VARIABLE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; RACE DIFFERENCE; RETROSPECTIVE STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DEVICES; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HISPANIC; INSURANCE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ORGANIZATION AND MANAGEMENT; RISK; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES; UTILIZATION;

AFRICAN AMERICANS; CALIFORNIA; CHI-SQUARE DISTRIBUTION; DRUG-ELUTING STENTS; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; LOGISTIC MODELS; MEDICAID; MEDICALLY UNINSURED; MEDICARE; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PRIVATE SECTOR; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84902544583     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2014.04.003     Document Type: Article

References (35)

1. Kirtane A.J., Gupta A., Iyengar S., Moses J.W., Leon M.B., Applegate R., et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009, 119:3198-3206.
2. Bangalore S., Kumar S., Fusaro M., Amoroso N., Attubato M.J., Feit F., et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012, 125:2873-2891.
3. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
4. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007, 356:1020-1029.
5. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356:998-1008.
6. Raber L., Wohlwend L., Wigger M., Togni M., Wandel S., Wenaweser P., et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation 2011, 123:2819-2828.
7. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005, 293:2126-2130.
8. Park D.W., Park S.W., Park K.H., Lee B.K., Kim Y.H., Lee C.W., et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006, 98:352-356.
9. Jeremias A., Sylvia B., Bridges J., Kirtane A.J., Bigelow B., Pinto D.S., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004, 109:1930-1932.
10. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER Registry. Circulation 2006, 113:2803-2809.
11. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., et al. American College of Cardiology F, American Heart Association Task Force on Practice G, Society for Cardiovascular A, Interventions. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011, 58:e44-e122.
12. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 61:e78-e140.
13. Conigliaro J., Whittle J., Good C.B., Hanusa B.H., Passman L.J., Lofgren R.P., et al. Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors. Arch Intern Med 2000, 160:1329-1335.
14. Groeneveld P.W., Heidenreich P.A., Garber A.M. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation 2003, 108:286-291.
15. Kressin N.R., Petersen L.A. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 2001, 135:352-366.
16. Sada M.J., French W.J., Carlisle D.M., Chandra N.C., Gore J.M., Rogers W.J. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction. J Am Coll Cardiol 1998, 31:1474-1480.
17. Sonel A.F., Good C.B., Mulgund J., Roe M.T., Gibler W.B., Smith S.C., et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 2005, 111:1225-1232.
18. Wenneker M.B., Weissman J.S., Epstein A.M. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA 1990, 264:1255-1260.
19. United States Census Bureau Median household income and median owner-occupied house value by zipcode Accessed January 10, 2013 at. http://factfinder.census.gov/servlet.
20. Centers for Disease Control, Prvention Use of stents among hospitalized patients undergoing coronary angioplasty, by race-United States, 2003. MMWR Morb Mortal Wkly Rep 2005, 54:310.
21. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., Krone R.J., et al. Patterns and outcomes of drug-eluting coronary stent use in clinical practice. Am Heart J 2006, 152:321-326.
22. Hannan E.L., Racz M., Walford G., Clark L.T., Holmes D.R., King S.B., et al. Differences in utilization of drug-eluting stents by race and payer. Am J Cardiol 2007, 100:1192-1198.
23. Gaglia M.A., Torguson R., Xue Z., Gonzalez M.A., Collins S.D., Ben-Dor I., et al. Insurance type influences the use of drug-eluting stents. JACC Cardiovasc Interv 2010, 3:773-779.
24. DuBard C.A., Garrett J., Gizlice Z. Effect of language on heart attack and stroke awareness among U.S. Hispanics. Am J Prev Med 2006, 30:189-196.
25. Cohen M.G., Fonarow G.C., Peterson E.D., Moscucci M., Dai D., Hernandez A.F., et al. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation 2010, 121:2294-2301.
26. Yarzebski J., Bujor C.F., Lessard D., Gore J.M., Goldberg R.J. Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: a population-based perspective. Am Heart J 2004, 147:690-697.
27. Echols M.R., Mahaffey K.W., Banerjee A., Pieper K.S., Stebbins A., Lansky A., et al. Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial). Am J Cardiol 2007, 99:315-321.
28. Freund K.M., Jacobs A.K., Pechacek J.A., White H.F., Ash A.S. Disparities by race, ethnicity, and sex in treating acute coronary syndromes. J Women's Health 2012, 21:126-132.
29. Kao J., Vicuna R., House J.A., Rumsfeld J.S., Ting H.H., Spertus J.A. Disparity in drug-eluting stent utilization by insurance type. Am Heart J 2008, 156:1133-1140.
30. Whittle J., Conigliaro J., Good C.B., Joswiak M. Do patient preferences contribute to racial differences in cardiovascular procedure use?. J Gen Intern Med 1997, 12:267-273.
31. Bangalore S., Amoroso N., Fusaro M., Kumar S., Feit F. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials. Circ Cardiovasc Interv 2013, 6:378-390.
32. Kumar R.S., Douglas P.S., Peterson E.D., Anstrom K.J., Dai D., Brennan J.M., et al. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases. Circulation 2013, 127:1395-1403.
33. Soobader M., LeClere F.B., Hadden W., Maury B. Using aggregate geographic data to proxy individual socioeconomic status: does size matter?. Am J Public Health 2001, 91:632-636.
34. Ross J.S., Bradley E.H., Busch S.H. Use of health care services by lower-income and higher-income uninsured adults. JAMA 2006, 295:2027-2036.
35. White House Office of Management and Budget Provisional guidance on the implementation of the 1997 standards for federal data on race and ethnicity Accessed August 16, 2013 at. http://www.whitehouse.gov/omb/fedreg_1997standards/.